An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.

The preventive and therapeutic mechanisms in multiple sclerosis are not clearly understood. We investigated whether Hyungbangpaedok-san (HBPDS), a traditional herbal medicine, has a beneficial effect in experimental autoimmune encephalomyelitis (EAE) mice immunized with myelin oligodendrocyte glycop...

Full description

Bibliographic Details
Main Authors: Jong Hee Choi, Min Jung Lee, Minhee Jang, Eun-Jeong Kim, Insop Shim, Hak-Jae Kim, Sanghyun Lee, Sang Won Lee, Young Ock Kim, Ik-Hyun Cho
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4596626?pdf=render
_version_ 1811338228933853184
author Jong Hee Choi
Min Jung Lee
Minhee Jang
Eun-Jeong Kim
Insop Shim
Hak-Jae Kim
Sanghyun Lee
Sang Won Lee
Young Ock Kim
Ik-Hyun Cho
author_facet Jong Hee Choi
Min Jung Lee
Minhee Jang
Eun-Jeong Kim
Insop Shim
Hak-Jae Kim
Sanghyun Lee
Sang Won Lee
Young Ock Kim
Ik-Hyun Cho
author_sort Jong Hee Choi
collection DOAJ
description The preventive and therapeutic mechanisms in multiple sclerosis are not clearly understood. We investigated whether Hyungbangpaedok-san (HBPDS), a traditional herbal medicine, has a beneficial effect in experimental autoimmune encephalomyelitis (EAE) mice immunized with myelin oligodendrocyte glycoprotein peptide (MOG 35-55). Onset-treatment with 4 types of HBPDS (extracted using distilled water and 30%/70%/100% ethanol as the solvent) alleviated neurological signs, and HBPDS extracted within 30% ethanol (henceforth called HBPDS) was more effective. Onset-treatment with HBPDS reduced demyelination and the recruitment/infiltration and activation of microglia/macrophages in the spinal cord of EAE mice, which corresponded to the reduced mRNA expression of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β), iNOS, and chemokines (MCP-1, MIP-1α, and RANTES) in the spinal cord. Onset-treatment with HBPDS inhibited changes in the components of the blood-brain barrier such as astrocytes, adhesion molecules (ICAM-1 and VCAM-1), and junctional molecules (claudin-3, claudin-5, and zona occludens-1) in the spinal cord of EAE mice. Onset-treatment with HBPDS reduced the elevated population of CD4+, CD4+/IFN-γ+, and CD4+/IL-17+ T cells in the spinal cord of EAE mice but it further increased the elevated population of CD4+/CD25+/Foxp3+ and CD4+/Foxp3+/Helios+ T cells. Pre-, onset-, post-, but not peak-treatment, with HBPDS had a beneficial effect on behavioral impairment in EAE mice. Taken together, HBPDS could alleviate the development/progression of EAE by regulating the recruitment/infiltration and activation of microglia and peripheral immune cells (macrophages, Th1, Th17, and Treg cells) in the spinal cord. These findings could help to develop protective strategies using HBPDS in the treatment of autoimmune disorders including multiple sclerosis.
first_indexed 2024-04-13T18:07:47Z
format Article
id doaj.art-ea9a94c2bd29495f8a2bc8fb1cbbf180
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T18:07:47Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ea9a94c2bd29495f8a2bc8fb1cbbf1802022-12-22T02:36:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e013859210.1371/journal.pone.0138592An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.Jong Hee ChoiMin Jung LeeMinhee JangEun-Jeong KimInsop ShimHak-Jae KimSanghyun LeeSang Won LeeYoung Ock KimIk-Hyun ChoThe preventive and therapeutic mechanisms in multiple sclerosis are not clearly understood. We investigated whether Hyungbangpaedok-san (HBPDS), a traditional herbal medicine, has a beneficial effect in experimental autoimmune encephalomyelitis (EAE) mice immunized with myelin oligodendrocyte glycoprotein peptide (MOG 35-55). Onset-treatment with 4 types of HBPDS (extracted using distilled water and 30%/70%/100% ethanol as the solvent) alleviated neurological signs, and HBPDS extracted within 30% ethanol (henceforth called HBPDS) was more effective. Onset-treatment with HBPDS reduced demyelination and the recruitment/infiltration and activation of microglia/macrophages in the spinal cord of EAE mice, which corresponded to the reduced mRNA expression of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β), iNOS, and chemokines (MCP-1, MIP-1α, and RANTES) in the spinal cord. Onset-treatment with HBPDS inhibited changes in the components of the blood-brain barrier such as astrocytes, adhesion molecules (ICAM-1 and VCAM-1), and junctional molecules (claudin-3, claudin-5, and zona occludens-1) in the spinal cord of EAE mice. Onset-treatment with HBPDS reduced the elevated population of CD4+, CD4+/IFN-γ+, and CD4+/IL-17+ T cells in the spinal cord of EAE mice but it further increased the elevated population of CD4+/CD25+/Foxp3+ and CD4+/Foxp3+/Helios+ T cells. Pre-, onset-, post-, but not peak-treatment, with HBPDS had a beneficial effect on behavioral impairment in EAE mice. Taken together, HBPDS could alleviate the development/progression of EAE by regulating the recruitment/infiltration and activation of microglia and peripheral immune cells (macrophages, Th1, Th17, and Treg cells) in the spinal cord. These findings could help to develop protective strategies using HBPDS in the treatment of autoimmune disorders including multiple sclerosis.http://europepmc.org/articles/PMC4596626?pdf=render
spellingShingle Jong Hee Choi
Min Jung Lee
Minhee Jang
Eun-Jeong Kim
Insop Shim
Hak-Jae Kim
Sanghyun Lee
Sang Won Lee
Young Ock Kim
Ik-Hyun Cho
An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
PLoS ONE
title An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
title_full An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
title_fullStr An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
title_full_unstemmed An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
title_short An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
title_sort oriental medicine hyungbangpaedok san attenuates motor paralysis in an experimental model of multiple sclerosis by regulating the t cell response
url http://europepmc.org/articles/PMC4596626?pdf=render
work_keys_str_mv AT jongheechoi anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT minjunglee anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT minheejang anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT eunjeongkim anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT insopshim anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT hakjaekim anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT sanghyunlee anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT sangwonlee anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT youngockkim anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT ikhyuncho anorientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT jongheechoi orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT minjunglee orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT minheejang orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT eunjeongkim orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT insopshim orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT hakjaekim orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT sanghyunlee orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT sangwonlee orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT youngockkim orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse
AT ikhyuncho orientalmedicinehyungbangpaedoksanattenuatesmotorparalysisinanexperimentalmodelofmultiplesclerosisbyregulatingthetcellresponse